Career Opportunities at MRC-Holland
MRC-Holland is a fast-growing biotechnology company based in the Amsterdam Baarsjes. MRC-Holland consists of a multinational team of more than 80 employees. MRC-Holland is the inventor of the Multiplex Ligation-dependent Probe Amplification (MLPA) technique, a sensitive method to detect copy number changes in genes. MLPA is used in hundreds of labs and hospitals worldwide for many different applications, including mutation detection in hereditary diseases and subtyping of tumours. Because of continuous growth, we are looking for:

new products
P474-CD274-PDCD1LG2-JAK2
Various cancer types
P480-WHS & Achondroplasia
Wolf Hirschhorn Syndrome, Achondroplasia
P478-SMARCE1
Meningioma, Coffin-Siris syndrome
P451-Chromosome 16
Breast cancer + various tumour types
improved products
P102-HBB
Thalassemia, beta-zero
ME011-MMR
Mismatch repair genes (MMR)
P253-NB mix 3
Neuroblastoma
P252-NB mix 2
Neuroblastoma
P056-TP53
Li-Fraumeni syndrome (LFS) and tumour analysis
Newsletter  |  Home  |  Site map  |  Terms and Conditions  |  Search  |  Copyright © 2018 MRC-Holland